PERIOPERATIVE BLOOD-TRANSFUSION AND GASTRIC-CANCER - ADVERSE-EFFECTS OR UNFAVORABLE CONDITIONS OF PRETREATMENT

被引：15

作者：

YAMAGUCHI, K

TOKUI, N

MAEDA, S

KOMINAMI, T

NAKAMURA, K

KITAMURA, K

机构：

[1] Department of Surgery, Shinkokura Hospital, Kitakyushu

[2] First Department of Surgery, Kyushu University, Faculty of Medicine, Fukuokan

[3] University of Occupations and Environmental Health, School of Nursing & Medical Technology, Kitakyushu

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1990年 / 60卷 / 10期

关键词：

gastric cancer; immunologic condition; perioperative blood transfusion;

D O I：

10.1111/j.1445-2197.1990.tb07471.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The use of perioperative blood transfusion (PBT), the immunological status pre‐operatively and at discharge from hospital. and the clinical course were examined retrospectively in 124 patients who underwent ‘curative’resection for gastric cancer at Shinkokura Hospital, Japan from 1979 to 1988. The general condition of patients with PBT was worse than that of those without PBT and the pre‐operative immunological status of patients with PBT was less favourable than that of those without PBT. At the time of discharge from hospital the immunological condition remained worse for patients who had been given PBT. Thc clinical course of patients with PBT was significantly worse. A dose‐response relationship was evident but the types of blood products did not influence the outcome. Cox regression analysis adjusting for potentially confounding prognostic factors revealed that the clinical course was not altered by perioperativc blood transfusion itself. These observations do not support the idea of adverse effects of perioperative blood transfusion on outcome of patients undergoing ‘curative’resection for gastric cancer. Copyright © 1990, Wiley Blackwell. All rights reserved

引用

页码：765 / 772

页数：8

共 58 条

[1]

Opelz G., Sengar D.P.S., Mickey M.R., Terasaki P.I., Effect of blood transfusion on subsequent kidney transplantation, Trans. Proc., 5, pp. 253-259, (1973)

[2]

Woodruff M.F.A., Van Rood J.J., Possible implications of the effect of blood transfusion on allograft survival, Lancet, 1, pp. 1201-1202, (1983)

[3]

Burrows L., Tartter P., Effects of blood transfusions on colonic malignancy recurrence rates, Lancet, 2, (1982)

[4]

Kaneda M., Horimi T., Ninomiya M., Et al., Adverse effect of blood transfusions on survival of patients with gastric cancer, Transfusion, 27, pp. 375-377, (1987)

[5]

Sugezawa A., Kaibara N., Sumi K., Et al., Blood transfusion and the prognosis of patients with gastric cancer, J. Surg. Oncol., 42, pp. 113-116, (1989)

[6]

The general rules for the gastric cancer study in surgery and pathology, Jpn J. Surg., 11, pp. 127-145, (1981)

[7]

SAS User's Guide. Statistics, 5, (1985)

[8]

Van Es A.A., Marquet R.L., Van Rood J.J., Balner H., Influence of a single blood transfusion on kidney allograft survival in unrelated rhesus monkeys, Transplantation, 26, pp. 325-330, (1978)

[9]

Francis D.M.A., Shenton B.K., Blood transfusion and tumor growth: Evidence from laboratory animals, Lancet, 2, (1981)

[10]

Horimi T., Kagawa S., Ninomiya M., Yoshida E., Hiramatsu S., Orita K., Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice, Acta Med. Okayama, 37, pp. 259-263, (1983)

← 1 2 3 4 5 6 →